利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

55 条记录 (耗时 0.04 秒)

    Monoclonal antibody
    31.
    发明申请
    Monoclonal antibody 有权
    单克隆抗体

    公开(公告)号：US20070166311A1

    公开(公告)日：2007-07-19

    申请号：US11637213

    申请日：2006-12-11

    申请人： Ruth Greferath ,  David Hickman ,  Andreas Muhs ,  Andrea Pfeifer ,  Claude Nicolau

    发明人： Ruth Greferath ,  David Hickman ,  Andreas Muhs ,  Andrea Pfeifer ,  Claude Nicolau

    IPC分类号： A61K39/395 ,  C07K16/40

    CPC分类号： C07K16/18 ,  A61K39/3955 ,  A61K2039/505 ,  G01N2333/4709 ,  A61K2300/00

    摘要： The present invention is related to methods and compositions for the therapeutic and diagnostic use in the treatment of diseases and disorders which are caused by or associated with amyloid or amyloid-like proteins including amyloidosis, a group of disorders and abnormalities associated with amyloid protein such as Alzheimer's disease. The present invention provides novel methods and compositions comprising highly specific and highly effective antibodies having the ability to specifically recognize and bind to specific epitopes from a range of β-amyloid proteins. The antibodies enabled by the teaching of the present invention are particularly useful for the treatment of diseases and disorders which are caused by or associated with amyloid or amyloid-like proteins including amyloidosis, a group of diseases and disorders associated with amyloid plaque formation including secondary amyloidosis and age-related amyloidosis including, but not limited to, neurological disorders such as Alzheimer's Disease (AD).

    摘要翻译： 本发明涉及用于治疗和诊断用途的方法和组合物，所述方法和组合物用于治疗由淀粉样蛋白或淀粉样蛋白样蛋白质引起或与之相关的疾病和病症，包括淀粉样变性，与淀粉样蛋白相关的一组障碍和异常，例如 阿尔茨海默氏病。 本发明提供新的方法和组合物，其包含具有特异性识别和结合来自β-淀粉样蛋白范围的特异性表位的能力的高度特异性和高效抗体。 通过本发明的教导实现的抗体特别可用于治疗由淀粉样蛋白或淀粉样蛋白样蛋白引起或与之相关的疾病和病症，包括淀粉样变性，与淀粉样斑块形成相关的一组疾病和病症，包括继发性淀粉样变性 和年龄相关的淀粉样变性病，包括但不限于神经障碍如阿尔茨海默病（AD）。

    NUCLEIC ACID MOLECULES ENCODING ANTI-AMYLOID-BETA ANTIBODIES
    35.
    发明申请
    NUCLEIC ACID MOLECULES ENCODING ANTI-AMYLOID-BETA ANTIBODIES 审中-公开
    编码抗淀粉样蛋白抗体的核酸分子

    公开(公告)号：US20120288896A1

    公开(公告)日：2012-11-15

    申请号：US13558256

    申请日：2012-07-25

    申请人： Ruth Greferath ,  Andreas Muhs ,  Andrea Pfeifer ,  Claude Nicolau

    发明人： Ruth Greferath ,  Andreas Muhs ,  Andrea Pfeifer ,  Claude Nicolau

    IPC分类号： C12N15/13 ,  C12P21/02 ,  C12N5/10 ,  C12N1/21 ,  C12N15/63

    CPC分类号： C07K16/18 ,  A61K39/3955 ,  A61K2039/505 ,  G01N2333/4709 ,  A61K2300/00

    摘要： The present invention is related to methods and compositions for the therapeutic and diagnostic use in the treatment of diseases and disorders which are caused by or associated with amyloid or amyloid-like proteins including amyloidosis, a group of disorders and abnormalities associated with amyloid protein such as Alzheimer's disease. The present invention provides novel methods and compositions comprising highly specific and highly effective antibodies having the ability to specifically recognize and bind to specific epitopes from a range of β-amyloid proteins. The antibodies enabled by the teaching of the present invention are particularly useful for the treatment of diseases and disorders which are caused by or associated with amyloid or amyloid-like proteins including amyloidosis, a group of diseases and disorders associated with amyloid plaque formation including secondary amyloidosis and age-related amyloidosis including, but not limited to, neurological disorders such as Alzheimer's Disease (AD).

    摘要翻译： 本发明涉及用于治疗和诊断用途的方法和组合物，所述方法和组合物用于治疗由淀粉样蛋白或淀粉状蛋白样蛋白质引起或与之相关的疾病和病症，包括淀粉样变性，与淀粉样蛋白相关的一组障碍和异常，例如 阿尔茨海默氏病。 本发明提供了包含高度特异性和高效抗体的新型方法和组合物，其具有特异性识别并结合来自一系列淀粉样蛋白质的特定表位的能力。 通过本发明的教导实现的抗体特别可用于治疗由淀粉样蛋白或淀粉样蛋白样蛋白引起或与之相关的疾病和病症，包括淀粉样变性，与淀粉样斑块形成相关的一组疾病和病症，包括继发性淀粉样变性 和年龄相关的淀粉样变性病，包括但不限于神经障碍如阿尔茨海默病（AD）。

    METHODS OF TREATING AMYLOIDOSIS COMPRISING THE USE OF ANTI-AMYLOID BETA ANTIBODIES
    36.
    发明申请
    METHODS OF TREATING AMYLOIDOSIS COMPRISING THE USE OF ANTI-AMYLOID BETA ANTIBODIES 审中-公开
    治疗包含抗Aβ抗体的AMYLOIDOSIS的方法

    公开(公告)号：US20120244165A1

    公开(公告)日：2012-09-27

    申请号：US13461658

    申请日：2012-05-01

    申请人： Ruth Greferath ,  Andreas Muhs ,  Andrea Pfeifer ,  Claude Nicolau

    发明人： Ruth Greferath ,  Andreas Muhs ,  Andrea Pfeifer ,  Claude Nicolau

    IPC分类号： A61K39/395 ,  A61P25/28

    CPC分类号： C07K16/18 ,  A61K39/3955 ,  A61K2039/505 ,  G01N2333/4709 ,  A61K2300/00

    摘要： The present invention is related to methods and compositions for the therapeutic and diagnostic use in the treatment of diseases and disorders which are caused by or associated with amyloid or amyloid-like proteins including amyloidosis, a group of disorders and abnormalities associated with amyloid protein such as Alzheimer's disease.The present invention provides novel methods and compositions comprising highly specific and highly effective antibodies having the ability to specifically recognize and bind to specific epitopes from a range of β-amyloid proteins. The antibodies enabled by the teaching of the present invention are particularly useful for the treatment of diseases and disorders which are caused by or associated with amyloid or amyloid-like proteins including amyloidosis, a group of diseases and disorders associated with amyloid plaque formation including secondary amyloidosis and age-related amyloidosis including, but not limited to, neurological disorders such as Alzheimer's Disease (AD).

    摘要翻译： 本发明涉及用于治疗和诊断用途的方法和组合物，所述方法和组合物用于治疗由淀粉样蛋白或淀粉样蛋白样蛋白质引起或与之相关的疾病和病症，包括淀粉样变性，与淀粉样蛋白相关的一组障碍和异常，例如 阿尔茨海默氏病。 本发明提供了包含高度特异性和高效抗体的新型方法和组合物，其具有特异性识别并结合来自一系列淀粉样蛋白质的特定表位的能力。 通过本发明的教导实现的抗体特别可用于治疗由淀粉样蛋白或淀粉样蛋白样蛋白引起或与之相关的疾病和病症，包括淀粉样变性，与淀粉样斑块形成相关的一组疾病和病症，包括继发性淀粉样变性 和年龄相关的淀粉样变性病，包括但不限于神经障碍如阿尔茨海默病（AD）。

    Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
    40.
    发明授权
    Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins 有权
    用于治疗与淀粉样蛋白或淀粉样样蛋白相关的疾病的化合物

    公开(公告)号：US08673940B2

    公开(公告)日：2014-03-18

    申请号：US13557770

    申请日：2012-07-25

    申请人： Wolfgang Froestl ,  Nampally Sreenivasachary ,  Sophie Lohmann ,  Maria Pilar Lopez Deber ,  Andreas Muhs ,  Maria Pihlgren Bosch

    发明人： Wolfgang Froestl ,  Nampally Sreenivasachary ,  Sophie Lohmann ,  Maria Pilar Lopez Deber ,  Andreas Muhs ,  Maria Pihlgren Bosch

    IPC分类号： A61K31/44

    CPC分类号： C07D401/12 ,  C07D213/74 ,  C07D213/75 ,  C07D231/38 ,  C07D277/42 ,  C07D403/12 ,  C07D405/04 ,  C07D409/14 ,  C07D417/12 ,  C07D417/14

    摘要： The present invention relates to novel compounds of formula (II) that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating, or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed.

    摘要翻译： 本发明涉及新的式（II）化合物，其可用于治疗与淀粉样蛋白（例如阿尔茨海默病）相关的一组疾病和异常以及与淀粉状蛋白样蛋白相关的疾病或病症。 本发明的化合物还可以用于治疗与视觉系统的组织中的病理学异常/变化相关的眼部疾病。 本发明还涉及包含这些化合物的药物组合物和这些化合物用于制备用于治疗或预防与淀粉样蛋白和/或淀粉样蛋白样蛋白相关的疾病或病症的药物的用途。 还公开了治疗或预防与淀粉样蛋白和/或淀粉样蛋白样蛋白相关的疾病或病症的方法。